Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) SHZ

17.87

+0.06000031(+0.34%)

Updated at December 25 03:04PM

Currency In CNY

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Address

Wuhan Optics Valley International Biomed

Wuhan, 430074

China

Phone

86 27 8700 1772

Sector

Healthcare

Industry

Medical - Devices

Employees

1063

First IPO Date

July 10, 2018

Key Executives

NameTitlePayYear Born
Chaohui LiAccounting Supervisor0N/A
Rui WangDeputy GM, Chief Financial Officer & Board Secretary01978
Chen Li LiChairman & GM01974
Wang YingVice Chairman & Deputy GM01974

Description

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.